YKL-05-099
YKL-05-099 is a salt-inducible kinase (SIK) inhibitor. YKL-05-099 binds to SIK1 and SIK3 with IC50s of ~10 and ~30 nM, respectively. YKL-05-099 has slightly less potent SIK2-inhibitory (IC50=40 nM) [1].
Product Specifications
CAS Number
[1936529-65-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Salt-inducible Kinase (SIK)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/YKL-05-099.html
Purity
99.76
Solubility
DMSO : ≥ 75 mg/mL
Smiles
O=C1N(C2=NC=C(OC)C=C2)C3=NC(NC4=CC=C(C5CCN(C)CC5)C=C4OC)=NC=C3CN1C6=C(C)C=CC=C6Cl
Molecular Formula
C32H34ClN7O3
Molecular Weight
600.11
Precautions
H302, H315, H319, H335
References & Citations
[1]Sundberg TB, et al. Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo. ACS Chem Biol. 2016 Aug 19;11 (8) :2105-11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SIK1; SIK3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6455931-01 0.2 mL
EXOC4 (Exocyst Complex Component 4, Exocyst Complex Component Sec8, EXOC4, KIAA1699, SEC8, SEC8L1) (AP)
Ask
View Details MBS6455931-02 5x 0.2 mL
EXOC4 (Exocyst Complex Component 4, Exocyst Complex Component Sec8, EXOC4, KIAA1699, SEC8, SEC8L1) (AP)
Ask
View Details